Antonio Chiesi, MD - CEO & CMO

Antonio Chiesi is the Foundeer of the Company, serving as CEO and CMO.

He is a Medical Doctor specialized in Neurology with a wide experience in pre-clinical and clinical research. Before establishing his innovative Biotech Companies in the exosome arena and committing to the Industrial sector he was Head of Research at the Department of Drug Research and Medicines Evaluation of the Italian National Institute of Health in Roma (Italy) for 20+ years, focusing in drug development in Cancer and HIV therapeutic areas.

He was Founding Member and CEO since 2007 of HansaBioMed (now HansaBioMed Life Sciences) in Tallinn – Estonia, the first company worldwide dedicated to design, production and sale of Life Science products for EV/exosome research. The Company was acquired by LONZA in April 2017.